Compound Detail
CHEMBL5221115
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5221115 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | IZIZVOZQIMDSBB-UHFFFAOYSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
326.4
MW (Da)
4.11
ALogP
3
HBA
2
HBD
67.8
PSA (Ų)
0.64
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.62
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 5.62 | 5.545 | 2400.0 | 2 |
| HepG2 CHEMBL395 | IC50 | 4.25 | 4.25 | 56200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Plasmodium falciparum | IC50 | = | 2400.0 | nM | 5.62 | Antiplasmodial activity against multidrug resistant asexual blood stage Plasmodi... | 33666415 |
| Plasmodium falciparum | IC50 | = | 3400.0 | nM | 5.47 | Antiplasmodial activity against chloroquine-sensitive asexual blood stage Plasmo... | 33666415 |
| HepG2 | IC50 | = | 56200.0 | nM | 4.25 | Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth inc... | 33666415 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33666415 | 10.1021/acs.jmedchem.0c01744 | Plasmodium falciparum | 2 |
| 33666415 | 10.1021/acs.jmedchem.0c01744 | HepG2 | 1 |
| 33666415 | 10.1021/acs.jmedchem.0c01744 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine